Gastrointestinal microbiome and cholelithiasis: Prospect in the nervous system

Area of Science:

• Microbiology and Neuroscience
• Gastroenterology

Background:

• Emerging research explores the gut microbiome's role in various health conditions.
• Cholelithiasis (gallstones) and choledocholithiasis are common gastrointestinal issues.
• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause neuroinflammation.

Purpose of the Study:

• To investigate the connection between the gastrointestinal microbiome and gallbladder diseases.
• To explore the interplay between the microbiota, S1 protein, and neuroinflammatory changes.
• To understand the potential of microbiota-targeted therapies for neurological disorders.

Main Methods:

• Review of existing literature on cholelithiasis and the gut microbiome.
• Analysis of potential mechanisms linking SARS-CoV-2, S1 protein, and neuroinflammation.
• Comparative analysis of microbial and neural pathways.

Main Results:

• The gastrointestinal microbiome composition is implicated in cholelithiasis.
• SARS-CoV-2 infection may influence neuroinflammatory pathways via the S1 protein.
• Similarities exist between microbial and neural pathways, such as GABA in schizophrenia and serotonin in Parkinson's disease.

Conclusions:

• The gut microbiome plays a role in gallbladder stone formation.
• Further research is warranted to elucidate the complex interactions between microbiota, neuroinflammation, and neurological conditions.
• Understanding these connections could lead to novel therapeutic strategies.